The American Cancer Society estimates that 67,400 Americans will be diagnosed with pancreatic cancer this year and nearly 52,000 will die from the disease.

Treatment for pancreatic cancer can include surgery, ablation, and immunotherapy, among others. Learn more.

Half of all pancreatic-cancer patients live less than a year after diagnosis. But researchers say there is potential for change.

Liver cancer and pancreatic cancer are two different types of cancer. However, pancreatic cancer can often spread to the liver. Learn more here.

The breakthrough, which targets the unique metabolic pathway used by cancer cells, could starve tumors while leaving the rest of the body unharmed.

A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study co-author Dr. Vinod Balachandran talks about the impact on future cancer care.

Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic and breast cancer.

In pancreatic cancer, a race against time Date: April 2, 2025 Source: Cold Spring Harbor Laboratory Summary: Scientists have found a way to 'intercept' pancreatic cancer. By inhibiting the cancer ...

Physician-scientist Conan Kinsey gives three reasons why pancreatic cancer has one of the lowest survival rates for any kind of cancer and explains how federally and donor-funded research provides ...

Pancreatic Cancer Surge May Be Less Worrisome Than It Seemed A rise in the disease in younger people was not followed by an increase in deaths, a study found, and might be a sign of overdiagnosis.

FRIDAY, Feb. 21, 2025 (HealthDay News) -- Adding a personalized mRNA vaccine to standard treatment could offer new hope for pancreatic cancer patients, a small yet promising study from Memorial ...

An enzyme called MICAL2 promotes tumor growth and spread in pancreatic ductal adenocarcinomas.